【2h】

A Study of

机译:一项研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Prostate cancer is one of the most widespread cancers among men throughout the world. In addition, it is the second cause of death after lung cancer. Occurrence of the prostate cancer is variable in various regions of the world. Solely, there are three known risk factors for the prostate cancer, including: Age, inheritance and ethnic origin. ELAC2 protein is a phosphodiesterase enzyme encoded by ELAC2 gene in human. This gene is placed on chromosome 17, and it is believed that product of the mentioned gene is an endonuclease contributed in puberty of mitochondrion’s tRNA. From clinical viewpoint, variables of ELAC2 gene such as Ser217Leu and Ala541Thr Missense mutations which are accompanied by hereditary prostate cancer (HPC2).Objective of this study is to investigate Ser217Leu (rs4792311) and Ala541Thr (rs5030739) polymorphisms in the individuals with prostate cancer or those who are suspicious of prostate cancer with family past record/history.
机译:前列腺癌是世界各地最普遍的癌症之一。此外,它是肺癌后第二次死亡原因。前列腺癌的发生在世界各个地区的变化。仅仅,有三种已知的前列腺癌风险因素,包括:年龄,遗产和族裔。 ELAC2蛋白是由人的ELAC2基因编码的磷酸二酶酶。将该基因置于染色体17上,并且据信该基因的产物是在线粒体的TRNA青春期产生的内切核酸酶。从临床观点来看,由遗传前列腺癌(HPC2)伴有Ser217Leu和Ala541th畸变突变的ELAC2基因的变量是该研究的目的是在具有前列腺癌中的个体中调查Ser217Leu(RS4792311)和ALA541THR(RS5030739)的多态性那些怀疑前列腺癌与家庭过去的记录/历史。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号